anderson
stanley
unit
state
von
ardenn
friedrichfreksa
schramm
germani
independ
report
electronmicroscop
studi
reaction
tobacco
mosaic
viru
tmv
antiserum
latter
group
investig
observ
mixtur
tmv
antitmv
rabbit
serum
result
aggreg
viru
particl
fig
wherea
contrast
aggreg
occur
viru
react
control
normal
rabbit
serum
fig
anderson
stanley
made
similar
observ
addit
demonstr
electronmicroscop
specif
reaction
observ
lack
reactiv
tmv
rabbit
antiserum
tomato
bushi
stunt
viru
fig
tomato
bushi
stunt
viru
antitmv
rabbit
serum
fig
studi
inde
first
demonstr
method
later
term
immun
immunoelectron
microscopi
iem
techniqu
may
defin
direct
observ
electron
microscopi
antigenantibodi
interact
ensu
year
spite
develop
electron
microscop
greater
resolv
power
method
neg
stain
von
ardenn
et
al
greatli
increas
contrast
techniqu
rel
underutil
azk
exposur
techniqu
came
guest
worker
month
laboratori
june
almeida
pioneer
applic
techniqu
anthoni
waterson
depart
virolog
royal
postgradu
medic
school
london
work
origin
antigen
serolog
studi
corona
virus
use
techniqu
iem
also
appli
techniqu
collabor
e
j
stott
studi
rhino
virus
sinc
agent
although
visibl
thin
section
infect
cell
purifi
prepar
fig
tobacco
mosaic
viru
tmv
tomato
bushi
stunt
viru
reaction
tomato
bushi
stunt
viru
rabbit
antiserum
tmv
aggreg
serum
wherea
tomato
bushi
stunt
viru
particl
aggreg
mudd
figur
reproduc
morton
studi
anderson
stanley
difficult
visual
partial
purifi
suspens
convent
neg
stain
techniqu
normal
grow
suffici
high
titer
display
distinct
morpholog
appear
neg
stain
among
smallest
virus
known
experi
rhinovirus
incub
either
phosphatebuff
salin
pb
homolog
goat
antiserum
centrifug
prepar
electron
microscopi
viru
particl
seen
specimen
greatli
differ
eas
certainti
recognit
figur
show
singl
particl
fig
tobacco
mosaic
viru
tmv
tomato
bushi
stunt
viru
treatment
tmv
rabbit
antiserum
tmv
particl
aggreg
serum
wherea
tomato
bushi
stunt
viru
particl
aggreg
mudd
figur
reproduc
morton
studi
anderson
stanley
rhinoviru
control
prepar
viru
grown
monolay
cell
cultur
titer
tcid
ml
react
pb
particl
shown
figur
probabl
viru
often
difficult
determin
certainti
whether
particular
structur
viru
particl
especi
sinc
even
probabl
viru
particl
seen
infrequ
figur
show
sever
rhinoviru
particl
anoth
control
prepar
particl
present
greater
number
sinc
suspens
prepar
spinner
cultur
higher
titer
tcid
ml
spite
still
difficult
certain
whether
particular
structur
viru
particl
prepar
scatter
particl
distribut
randomli
grid
squar
contrast
viru
homolog
goat
antiserum
mixtur
larg
small
aggreg
observ
fig
singl
particl
rhinoviru
control
prepar
rhinoviru
incub
phosphatebuff
salin
prior
prepar
electron
microscopi
particl
randomli
distribut
difficult
determin
whether
certain
object
viru
particl
bar
nm
kapikian
et
al
shown
rhinoviru
fig
particl
longer
randomli
distribut
present
aggreg
stood
clearli
background
matter
longer
doubt
appear
viru
sinc
virusantibodi
reaction
result
format
distinct
aggreg
could
easili
visual
shown
also
rhinoviru
fig
optim
antibodi
concentr
result
maxim
clump
particl
wherea
extrem
antibodi
excess
tend
obscur
particl
also
often
hinder
format
aggreg
studi
occur
techniqu
iem
distinct
featur
increas
sensit
detect
facilit
enabl
recognit
specif
lowtit
agent
virtu
immunolog
specif
antibodi
fig
sever
rhinoviru
particl
anoth
control
prepar
rhinoviru
incub
phosphatebuff
salin
prior
prepar
electron
microscopi
particl
present
greater
number
fig
sinc
rhinoviru
suspens
higher
titer
still
difficult
determin
whether
certain
object
viru
particl
particl
randomli
distribut
bar
nm
kapikian
et
al
agent
might
success
appli
practic
way
detect
identif
fastidi
agent
human
diseas
patient
convalesc
serum
could
util
sourc
specif
antibodi
hope
latter
would
enabl
detect
identif
otherwis
unidentifi
lowtit
fastidi
agent
patient
therefor
follow
return
nation
institut
health
began
look
one
fastidi
agent
human
diseas
coronavirus
use
iem
coronavirus
shown
sever
seroepidemiolog
studi
uncommon
adult
popul
spite
recoveri
agent
quit
rare
thirtytwo
isol
report
sinc
first
strain
recov
human
embryon
trachea
organ
cultur
hetoc
tyrrel
byno
ten
thirtytwo
origin
isol
hetoc
identifi
convent
electron
microscopi
wherea
remaind
similar
prototyp
strain
design
recov
difficulti
monolay
cell
cultur
attempt
find
new
method
detect
fastidi
agent
adapt
techniqu
iem
studi
hetoc
harvest
deriv
wash
adult
upper
respiratori
tract
ill
method
recov
one
thirtytwo
coronaviru
strain
studi
describ
dilut
nasalnasopharyng
wash
nih
employe
studi
enrol
common
cold
studi
inocul
roller
tube
cell
cultur
primari
rhesu
monkey
kidney
mk
primari
human
embryon
kidney
semicontinu
human
embryon
intestin
cultur
human
diploid
cell
strain
sinc
neither
cytopath
effect
cpe
hemadsorpt
mk
cell
cultur
observ
dilut
wash
carri
three
passag
hetoc
harvest
variou
day
third
passag
pool
inocul
roller
tube
cell
cultur
previous
mention
except
sinc
neither
cpe
hemadsorpt
observ
pool
harvest
third
hetoc
passag
examin
presenc
viru
particl
iem
util
patient
convalesc
serum
sourc
specif
antibodi
hope
viru
particl
present
would
appear
form
aggreg
therebi
enabl
visual
lowtit
coronaviru
suspens
might
detect
without
reaction
specif
antibodi
convalesc
serum
briefli
procedur
involv
incub
ml
organ
cultur
harvest
hour
room
temperatur
ml
dilut
patient
uninactiv
convalesc
serum
also
ml
pb
latter
control
iem
procedur
ml
pb
ad
tube
mixtur
centrifug
rpm
minut
sorval
centrifug
fixedangl
rotor
supernat
fluid
discard
pellet
residu
resuspend
drop
distil
water
stain
pta
place
formvar
carbonco
grid
excess
fluid
withdrawn
filter
paper
grid
examin
magnif
approxim
siemen
elmiskop
electron
microscop
reaction
organ
cultur
harvest
patient
convalesc
serum
result
appear
larg
small
aggreg
coronaviruslik
particl
appear
heavili
coat
antibodi
fig
b
c
particl
randomli
distribut
present
almost
exclus
group
stood
clearli
surround
matter
interestingli
singl
particl
ap
human
embryon
organ
cultur
harvest
deriv
wash
patient
nih
common
cold
studi
incub
dilut
patient
convalesc
serum
prior
prepar
electron
microscopi
particl
heavili
coat
antibodi
randomli
distribut
present
almost
pear
cover
littl
antibodi
fig
also
observ
examin
hetoc
harvestpb
mixtur
reveal
coronaviru
paricl
predominantli
round
ovalshap
structur
fig
addit
studi
made
iem
determin
coronaviru
strain
design
relat
coronavirus
known
distinct
coronavirus
human
origin
abl
propag
either
cell
cultur
anim
system
laboratori
serolog
test
iem
presenc
absenc
aggreg
differ
sera
use
measur
serolog
reactiv
aggreg
although
less
numer
initi
experi
observ
follow
incub
strain
homolog
convalesc
serum
specif
anim
antisera
two
coronavirus
indic
test
system
strain
relat
serolog
strain
thu
techniqu
iem
enabl
detect
fastidi
coronaviru
also
demonstr
serolog
distinct
also
attempt
util
iem
techniqu
identif
fastidi
agent
acut
infecti
nonbacteri
gastroenter
sinc
spite
intens
effort
etiolog
agent
syndrom
found
selflimit
diseas
character
spectrum
clinic
symptom
may
includ
vomit
diarrhea
abdomin
pain
combin
thereof
affect
broad
segment
popul
second
common
diseas
experi
cleveland
famili
studi
diseas
given
variou
descript
name
winter
vomit
diseas
epidem
diarrhea
vomit
transmit
volunt
recent
attempt
cultiv
character
definit
etiolog
agent
vitro
fail
one
studi
dolin
et
al
filtrat
prepar
rectal
swab
specimen
adult
develop
secondari
case
acut
nonbacteri
gastroenter
outbreak
norwalk
exclus
group
stood
clearli
surround
matter
singl
particl
coronaviru
strain
also
found
grid
particl
b
c
observ
particl
appear
cover
littl
antibodi
bar
nm
kapikian
et
al
human
embryon
organ
cultur
harvest
wash
patient
incub
phosphatebuff
salin
prior
prepar
electron
microscopi
experi
describ
fig
coronaviru
particl
observ
predominantli
round
ovalshap
object
bar
nm
kapikian
et
al
ohio
induc
typic
ill
two
three
volunt
follow
oral
administr
serial
passag
two
addit
time
volunt
dolin
et
al
induc
typic
ill
character
studi
volunt
reveal
infecti
agent
norwalk
outbreakderiv
filtrat
less
nm
diamet
probabl
less
nm
addit
inactiv
ether
acid
heat
minut
howev
attempt
cultiv
infecti
agent
cell
cultur
anim
uniformli
unsuccess
attempt
human
embryon
intestin
organ
cultur
inconclus
attempt
detect
fastidi
presum
viral
gastroener
agent
adapt
techniqu
ie
studi
stool
filtrat
deriv
norwalk
outbreak
second
human
passag
norwalkderiv
stool
filtrat
design
use
antigen
iem
studi
filter
membran
filter
known
contain
infecti
agent
sinc
induc
gastroenter
volunt
extens
attempt
recov
detect
etiolog
agent
convent
techniqu
unsuccess
therefor
examin
filtrat
presenc
viru
particl
iem
util
coronaviru
studi
volunt
convalesc
serum
sourc
specif
antibodi
serum
obtain
experiment
infect
volunt
develop
typic
ill
approach
taken
hope
viru
particl
would
appear
form
aggreg
therebi
enabl
visual
recognit
viral
agent
present
low
titer
iem
techniqu
similar
outlin
previous
coronaviru
studi
except
minor
modif
reaction
ml
stool
filtrat
ml
dilut
convalesc
serum
result
appear
aggreg
viruslik
particl
fig
particl
heavili
coat
antibodi
randomli
distribut
present
group
stood
clearli
surround
matter
could
easili
differenti
round
structur
group
round
structur
devoid
antibodi
stool
filtrat
morpholog
antibodyco
particl
resembl
picornaor
parvovirus
stool
filtratepb
control
prepar
particl
group
particl
without
littl
appar
antibodi
seen
rare
comparison
signific
would
difficult
evalu
without
previou
experi
examin
similar
heavili
coat
particl
aggreg
antibodi
particl
measur
approxim
nm
shortest
nm
longest
diamet
use
stool
filtrat
readili
detect
particl
iem
examin
sever
group
pair
sera
antibodi
viruslik
antigen
order
determin
particl
relat
gastroenter
manner
similar
describ
coronaviru
studi
ml
dilut
uninactiv
serum
incub
ml
stool
filtrat
prepar
iem
antibodi
evalu
made
code
specimen
order
elimin
possibl
bias
interpret
routin
five
squar
grid
examin
rel
concentr
antibodi
serum
specimen
estim
judg
amount
antibodi
coat
aggreg
particl
scale
three
particl
group
consid
constitut
aggreg
rate
ie
antibodi
assign
aggreg
seen
wherea
rate
indic
aggreg
particl
heavili
coat
antibodi
almost
obscur
singl
pair
particl
heavili
coat
antibodi
therebi
enabl
easi
recognit
observ
along
aggreg
convalesc
sera
high
level
antibodi
rate
indic
presenc
antibodi
lesser
amount
rate
chang
antibodi
rate
pair
sera
consid
signific
exampl
aggreg
score
shown
fig
serum
volunt
score
sinc
particl
welldefin
appear
cover
littl
antibodi
wherea
volunt
b
score
sinc
particl
heavili
coat
antibodi
almost
obscur
heavili
coat
particl
usual
found
small
aggreg
singl
pair
unit
wherea
less
antibodi
usual
form
larger
aggreg
exampl
consid
signific
serorespons
observ
iem
singl
volunt
pair
sera
shown
fig
seen
tabl
volunt
develop
gastroenter
follow
administr
second
human
passag
norwalk
stool
filtrat
develop
serolog
evid
infect
particl
determin
iem
fifth
volunt
develop
ill
demonstr
signific
antibodi
respons
agent
repres
aggreg
observ
iem
volunt
preand
postinocul
sera
rate
respect
shown
fig
aggreg
observ
pbsnorwalk
stool
filtrat
mixtur
control
util
certain
serolog
studi
tabl
although
volunt
develop
ill
challeng
stool
filtrat
develop
serolog
evid
infect
possibl
observ
particl
might
repres
viru
relat
etiolog
agent
norwalk
outbreak
sinc
conceiv
adventiti
agent
could
either
present
stool
patient
origin
norwalk
outbreak
could
acquir
passag
volunt
examin
possibl
test
pair
sera
individu
origin
norwalk
outbreak
four
primari
case
secondari
case
contact
becom
ill
serum
sampl
kindli
suppli
dr
hatch
adler
zickl
shown
tabl
individu
natur
acquir
norwalk
gastroenter
develop
increas
antibodi
particl
determin
test
pair
sera
iem
wherea
show
increas
demonstr
high
level
antibodi
acut
convalesc
sera
acut
stool
filtrat
ml
dilut
volunt
prechalleng
serum
prepar
electron
microscopi
volunt
develop
gastroenter
follow
challeng
second
passag
norwalk
filtrat
heat
minut
quantiti
antibodi
particl
aggreg
rate
prechalleng
serum
given
overal
rate
b
singl
particl
c
three
singl
particl
observ
incub
ml
norwalk
stool
filtrat
ml
dilut
volunt
post
challeng
convalesc
serum
prepar
em
particl
heavili
coat
antibodi
quantiti
antibodi
particl
rate
serum
given
overal
rate
differ
quantiti
antibodi
coat
particl
prechalleng
postchalleng
sera
volunt
clearli
evid
bar
nm
appli
b
c
phase
sera
collect
sever
day
onset
diseas
could
explain
failur
detect
respons
patient
contact
becom
ill
exhibit
serum
respons
interest
among
serorespond
donor
j
origin
rectal
swab
specimen
use
induc
ill
volunt
studi
examin
iem
prechalleng
convalesc
sera
volunt
found
develop
increas
antibodi
wherea
develop
signific
increas
antibodi
individu
natur
induc
ill
suggest
strongli
particl
adventiti
agent
acquir
passag
volunt
furthermor
indic
viruslik
agent
also
infect
patient
norwalk
outbreak
final
investig
possibl
gastrointestin
diseas
might
stimul
observ
antibodi
respons
nonspecif
mechan
anoth
studi
volunt
first
administ
either
stool
filtrat
contain
infecti
agent
secondari
case
gastroenter
occur
honolulu
hawaii
secondari
case
occur
montgomeri
counti
maryland
volunt
becam
ill
primari
challeng
later
rechalleng
agent
homolog
immun
demon
strate
subsequ
challeng
filtrat
deriv
norwalk
outbreak
produc
diseas
indic
infecti
agent
filtrat
deriv
hawaii
maryland
case
differ
norwalk
sequenti
sera
volunt
underw
sequenc
three
challeng
describ
studi
iem
norwalk
filtrat
antigen
tabl
volunt
receiv
filtrat
deriv
hawaii
case
fail
develop
increas
antibodi
follow
gastroenter
induc
primari
challeng
develop
signific
respons
ill
induc
norwalk
filtrat
suggest
iem
serorespons
specif
volunt
develop
increas
antibodi
gastroenter
induc
primari
challeng
increas
ill
induc
norwalk
filtrat
suggest
infecti
agent
maryland
norwalk
filtrat
may
antigen
relat
data
studi
suggest
norwalk
particl
etiolog
agent
norwalk
gastroenter
addit
evid
support
view
emerg
recent
studi
laboratori
techniqu
iem
use
determin
shed
pattern
norwalk
agent
studi
reveal
iem
presenc
norwalk
particl
stool
filtrat
deriv
volunt
develop
ill
follow
challeng
norwalk
outbreakderiv
stool
filtrat
total
seventyseven
stool
filtrat
studi
iem
use
singl
convalesc
serum
known
contain
high
level
antibodi
norwalk
particl
noteworthi
particl
observ
none
specimen
obtain
prior
onset
ill
collect
first
hour
onset
ill
obtain
hour
follow
onset
ill
tabul
total
number
particl
observ
iem
five
grid
squar
stool
filtrat
deriv
serial
stool
sampl
particleposit
volunt
reveal
shed
particl
maxim
onset
experiment
ill
shortli
thereaft
fig
three
particleposi
aggreg
observ
incub
ml
norwalk
stool
filtrat
ml
dilut
immun
human
serum
globulin
follow
prepar
electron
microscopi
particl
heavili
coat
antibodi
quantiti
antibodi
particl
rate
b
c
overal
rate
dilut
immun
human
serum
globulin
bar
nm
appli
ad
tive
volunt
exclud
figur
posit
stool
contain
one
particl
stool
collect
hour
onset
symptom
pool
interest
studi
ie
found
incub
norwalk
filtrat
dilut
aliquot
prepar
commerci
immun
human
serum
globulin
result
appear
particl
heavili
coat
antibodi
shown
fig
indic
antibodi
relat
agent
must
occur
rare
gener
popul
also
recent
shown
volunt
develop
gastroenter
follow
oral
administr
w
gastroenter
agent
clark
et
al
develop
serolog
evid
infect
iem
norwalk
agent
indic
two
agent
probabl
relat
serolog
develop
ill
volunt
studi
clark
et
al
studi
laboratori
collabor
univers
maryland
addit
anoth
studi
laboratori
iem
util
success
transmiss
norwalk
particl
chimpanze
demonstr
although
ill
occur
serolog
evid
infect
particl
shown
iem
addit
studi
collabor
dr
john
gerin
determin
buoyant
densiti
particl
cesium
chlorid
examin
sixteen
gradient
fraction
iem
use
appropri
human
serum
aggreg
particl
total
number
particl
gradient
determin
number
fraction
express
percentag
total
number
particl
highest
percentag
particl
seen
fraction
mean
densiti
fig
exampl
aggreg
observ
fraction
fraction
second
highest
percentag
particl
shown
fig
two
addit
isopycn
band
experi
cesium
chlorid
peak
fraction
found
iem
densiti
gmcm
respect
basi
buoyant
densiti
appear
norwalk
agent
enteroviru
latter
lower
buoyant
densiti
cesium
chlorid
although
norwalk
agent
densiti
tabl
b
aggreg
observ
fraction
c
aggreg
fraction
kapikian
et
al
similar
rhinoviru
cesium
chlorid
also
exclud
subgroup
picornavirus
sinc
rhinovirus
acidlabil
wherea
infecti
stool
filtrat
deriv
norwalk
outbreak
shown
dolin
et
al
acid
stabl
although
nucleic
acid
content
norwalk
particl
yet
determin
appear
agent
previous
suggest
dolin
et
al
volunt
studi
parvoviruslik
sinc
similar
buoyant
densiti
cesium
chlorid
also
share
properti
group
morpholog
shown
volunt
studi
cite
ether
acid
rel
heat
stabil
conclus
phase
gastroenter
studi
began
look
ie
fastidi
agent
hepat
stool
filtrat
obtain
differ
sourc
util
techniqu
similar
gastroenter
studi
stool
specimen
studi
describ
suppli
code
normal
salin
extract
dr
dean
gibson
arm
forc
institut
patholog
extract
consist
supernat
fluid
approxim
fecal
suspens
normal
salin
shaken
homogen
centrifug
low
speed
origin
specimen
obtain
adult
volunt
joliet
illinoi
studi
develop
hepat
receiv
either
oral
parenter
strain
hepat
viru
extract
deriv
stool
obtain
prior
challeng
acut
phase
ill
volunt
dilut
suspens
pass
membran
filter
stool
filtrat
examin
ie
use
volunt
convalesc
phase
serum
sourc
specif
antibodi
reason
similar
gastroenter
studi
commerci
immun
human
serum
globulin
also
use
examin
two
pair
filtrat
previous
describ
approach
found
small
viruslik
particl
measur
approxim
nm
diamet
one
two
stool
filtrat
deriv
stool
volunt
acut
phase
diseas
filtrat
incub
either
volunt
convalesc
phase
serum
human
immun
serum
globulin
signific
particl
observ
two
stool
filtrat
deriv
prechalleng
stool
two
volunt
incub
filtrat
convalesc
serum
immun
serum
globulin
particl
stood
clearli
surround
matter
easili
differenti
numer
spheric
object
usual
found
stool
filtrat
former
occur
either
singl
particl
heavili
coat
antibodi
particl
group
aggreg
antibodi
fig
later
studi
found
similar
appear
particl
much
fewer
number
occur
singl
particl
one
two
stool
filtrat
deriv
stool
fig
hepat
viruslik
particl
observ
ml
stool
filtrat
incub
ml
dilut
convalesc
serum
dilut
immun
human
serum
globulin
follow
prepar
electron
microscopi
aggreg
singl
particl
b
doublet
c
observ
follow
incub
stool
filtrat
convalesc
serum
patient
joliet
illinoi
studi
particl
heavili
coat
antibodi
quantiti
antibodi
serum
hepat
particl
rate
e
f
g
hepat
viruslik
particl
observ
follow
incub
ml
stool
filtrat
immun
serum
globulin
particl
heavili
coat
antibodi
also
quantiti
antibodi
lot
immun
serum
globulin
hepat
particl
also
score
bar
nm
appli
ag
micrograph
b
f
g
feinston
et
al
usual
ml
dilut
uninactiv
serum
mix
ml
stool
filtrat
examin
iem
minor
modif
techniqu
use
gastroenter
studi
rel
concentr
antibodi
serum
specimen
estim
score
amount
antibodi
coat
particl
scale
one
differ
gastroenter
hepat
filtrat
latter
contain
fewer
particl
therefor
presenc
antibodi
hepat
antigen
occur
frequent
individu
particl
coat
antibodi
less
often
form
antigenantibodi
aggreg
howev
although
particl
fewer
rate
antibodi
somewhat
simplifi
sinc
antibodyco
singl
particl
gener
quickli
visibl
sinc
appear
randomli
distribut
wherea
aggreg
gener
antibodi
evalu
pair
sera
made
code
specimen
order
elimin
possibl
bias
interpret
four
pair
sera
experiment
infect
hepat
individu
joliet
illinoi
studi
pair
sera
experiment
infect
hepat
individu
willowbrook
new
york
studi
examin
method
shown
tabl
experiment
infect
hepat
patient
develop
serolog
evid
infect
hepat
viruslik
particl
determin
iem
howev
sinc
hepat
contain
inoculum
use
experiment
studi
deriv
sourc
conceiv
serorespons
might
due
unknown
adventiti
agent
origin
inoculum
thu
may
relationship
hepat
examin
possibl
test
pair
sera
individu
develop
hepat
small
natur
occur
hepat
outbreak
american
samoa
addit
individu
develop
diseas
natur
occur
hepat
outbreak
massachusett
holi
cross
colleg
footbal
team
outbreak
found
shown
tabl
develop
serolog
evid
infect
hepat
particl
iem
therebi
suggest
strongli
particl
adventiti
agent
heavili
coat
particl
observ
follow
reaction
stool
filtrat
convalesc
serum
american
samoan
convalesc
serum
massachusett
outbreak
shown
fig
experi
design
determin
whether
serolog
relationship
exist
hepat
particl
hepat
b
antigen
found
shown
tabl
none
serorespond
hepat
antigen
develop
serolog
respons
hepat
b
antigen
radioimmunoassay
b
individu
hepat
b
demonstr
serolog
respons
hepat
b
antigen
radioimmunoassay
develop
serorespons
hepat
antigen
iem
c
neither
guinea
pig
hyperimmun
serum
hepat
b
antigen
guinea
pig
serum
core
dane
particl
react
hepat
antigen
iem
therefor
could
detect
relationship
hepat
antigen
hepat
b
antigen
also
studi
possibl
antigen
relationship
hepat
norwalk
particl
iem
sinc
similar
morpholog
also
sinc
infecti
hepat
serum
infecti
norwalk
stool
filtrat
shown
provost
et
al
dolin
et
al
respect
ether
acid
rel
heat
stabl
infect
studi
could
demonstr
serolog
respons
iem
norwalk
particl
pair
sera
volunt
experiment
induc
hepat
serorespons
hepat
antigen
could
demonstr
serolog
respons
ie
hepat
antigen
pair
sera
volunt
experiment
induc
norwalk
gastroenter
serorespons
norwalk
agent
indic
two
agent
probabl
serolog
relat
previou
studi
viru
recov
cell
cultur
inocul
specimen
volunt
illinoi
studi
viru
later
shown
parvoviru
relat
latent
rat
viru
complex
agent
although
isol
like
contamin
unrel
hepat
possibl
associ
hepat
particl
examin
guinea
pig
hyperimmun
serum
kilham
strain
latent
rat
viru
rat
viru
antigen
grown
cell
cultur
reciproc
crossi
studi
done
code
convalesc
phase
hepat
serum
joliet
volunt
react
rat
viru
antigen
homolog
hepat
antigen
hyperimmun
rat
viru
serum
react
hepat
antigen
homolog
rat
viru
antigen
thu
could
conclud
hepat
antigen
relat
rat
viru
addit
lack
etiolog
relationship
rat
viru
hepat
confirm
feinston
et
al
b
antibodi
hepat
antigen
detect
immun
electron
microscopi
iem
rate
scale
depend
amount
antibodi
coat
particl
antibodi
gastroenter
antigen
determin
way
antibodi
hepat
b
antigen
measur
radioimmunoassay
ria
first
serum
serum
pair
list
obtain
prior
exposur
except
case
four
sera
obtain
acut
phase
ill
acut
second
serum
pair
obtain
approxim
month
onset
ill
sera
test
e
initi
dilut
except
sera
patient
j
k
l
test
approxim
sera
patient
e
f
test
sera
test
ria
dilut
also
test
anoth
lot
immun
human
serum
globulin
antibodi
hepat
antigen
iem
found
contain
less
antibodi
previous
studi
strongli
posit
lot
see
fig
test
may
prove
use
potenc
standard
immun
serum
globulin
use
prevent
hepat
data
iem
studi
suggest
particl
visual
stool
filtrat
deriv
patient
hepat
etiolog
agent
diseas
addit
detect
agent
stool
hepat
patient
develop
serolog
techniqu
determin
antibodi
provid
way
diagnos
studi
hepat
collabor
dr
john
gerin
attempt
character
hepat
viruslik
particl
determin
buoyant
densiti
cesium
chlorid
util
iem
observ
distribut
particl
dilut
fraction
densiti
gradient
use
minor
modif
method
employ
previous
norwalk
particl
convalesc
serum
known
contain
antibodi
hepat
particl
patient
natur
acquir
hepat
american
samoa
use
iem
studi
studi
origin
approxim
stool
extract
shown
tenfold
dilut
filtrat
posit
hepat
particl
studi
iem
previous
describ
method
studi
stool
extract
deriv
volunt
acut
phase
ill
found
peak
fraction
particl
buoyant
densiti
approxim
gmcm
cesium
chlorid
shown
fig
figur
show
aggreg
hepat
particl
observ
iem
mean
densiti
cesium
chlorid
gmcm
fraction
previou
isopycn
band
studi
stool
extract
anoth
volunt
four
consecut
fraction
reexamin
repeat
iem
studi
peak
number
particl
found
fraction
detail
initi
iem
studi
describ
legend
fig
densiti
hepat
particl
approxim
gmcm
consist
parvoviru
rhinoviru
enteroviru
although
antigen
densiti
similar
rhinoviru
also
exclud
subgroup
picornavirus
sinc
rhinovirus
acidlabil
wherea
infecti
hepat
serum
shown
provost
et
al
acidst
studi
marmoset
although
nucleic
acid
content
hepat
particl
yet
determin
appear
agent
parvoviruslik
sinc
similar
buoyant
densiti
cesium
chlorid
also
share
properti
parvovirus
morpholog
shown
provost
et
al
studi
marmoset
infecti
hepat
serum
acid
ether
rel
heat
stabil
attempt
show
use
techniqu
iem
detect
fastidi
agent
human
diseas
norwalk
gastroenter
hepat
techniqu
enabl
definit
visual
identif
first
time
viruslik
particl
individu
diseas
also
enabl
us
demonstr
first
time
serolog
associ
identifi
viruslik
agent
diseas
noteworthi
accomplish
without
benefit
cell
cultur
anim
system
certain
techniqu
mani
applic
practic
type
virus
directli
recoveri
isol
latter
alreadi
shown
anderson
doan
possibl
certain
entero
virus
also
recent
abl
type
rhinoviru
iem
react
cell
cultur
isol
fig
aggreg
hepat
particl
observ
immun
electron
microscopi
iem
mean
densiti
gmcm
cesium
chlorid
particl
dilut
fraction
fraction
aggreg
dilut
late
convalesc
serum
patient
natur
acquir
hepat
four
consecut
fraction
gradient
initi
isopycn
band
experi
reexamin
repeat
iem
studi
peak
fraction
particl
found
serum
pool
contain
antibodi
eightynin
number
rhinovirus
plu
subtyp
j
follow
individu
test
iem
isol
serum
pool
aggreg
viru
howev
reward
excit
use
techniqu
applic
quest
multitud
fastidi
agent
human
diseas
cultiv
cultiv
effect
vitro
vivo
system
eleg
result
report
dr
kapikian
prompt
report
anoth
techniqu
besid
immunoelectron
microscopi
avail
kind
studi
dr
ralph
debloi
associ
gener
electr
schenectadi
develop
new
method
size
count
viru
particlesth
electr
resist
puls
analysi
e
r
p
erp
techniqu
viru
particl
fluid
flow
microcylindr
pore
made
gener
electr
nucleopor
process
plastic
sheet
detect
disturb
produc
electr
voltag
appli
across
pore
individu
viru
particl
size
count
techniqu
essenti
involv
extens
exist
coulter
counter
particl
viru
size
virus
concentr
l
size
count
time
approxim
minut
date
techniqu
appli
polyomaviru
phage
mous
leukemia
viru
mous
mammari
tumor
viru
dr
sam
mayassi
associ
charl
pfizer
co
may
wood
use
techniqu
size
count
viru
particl
routin
product
oncornaviru
stock
demonstr
addit
specif
antisera
caus
format
aggreg
detect
resist
puls
analyz
although
occasion
plug
pore
virusantibodi
complex
still
present
mechan
difficulti
problem
appear
solvabl
techniqu
appear
amen
applic
detect
virus
virusantibodi
complex
forego
result
dr
debloi
associ
dr
mayassi
associ
execut
molecular
control
program
nation
cancer
institut
report
spring
meet
american
associ
cancer
research
houston
dr
kapikian
report
origin
gastroenter
studi
immun
electron
microscopi
took
median
time
approxim
hour
examin
specimen
order
assign
antibodi
rate
nt
take
us
quit
long
hepat
studi
rate
took
less
time
hepat
antigen
use
origin
studi
contain
fewer
particl
norwalk
gastroenter
antigen
therefor
presenc
specif
antibodi
hepat
particl
randomli
distribut
occur
often
antibodyco
singl
particl
gener
serolog
studi
immun
electron
microscopi
quit
time
consum
system
mention
would
certainli
great
boon
us
applic
serolog
studi
r
melnick
two
distinct
virus
pass
marmoset
hepat
patient
one
deinhardt
group
second
hilleman
group
examin
pair
sera
marmoset
two
laboratori
acut
sera
three
joliet
volunt
report
isol
morpholog
similar
viru
illfat
cellsat
time
show
hepat
suscept
serial
passag
appear
virus
replac
contamin
rodent
parvoviru
would
interest
examin
sera
volunt
determin
sera
also
posit
viru
immun
electron
microscopi
dr
kapikian
first
respons
second
question
dr
feinston
purcel
studi
sera
joliet
studi
specif
purpos
tri
detect
hepat
particl
immun
electron
microscopi
yet
hope
studi
soon
second
examin
marmoset
sera
antibodi
hepat
particl
sourc
mention
dr
koch
method
use
get
estim
number
antibodi
molecul
bound
one
viru
particl
dr
kapikian
n
nt
think
techniqu
enabl
estim
made
get
gener
idea
amount
antibodi
coat
particl
assign
rate
occasion
see
think
bridg
antibodi
molecul
two
particl
limit
resolut
electron
microscopi
nt
think
could
estim
number
small
molecul
viru
particl
techniqu
immun
electron
microscopi
use
dr
hall
would
like
compliment
dr
kapikian
colleagu
beauti
work
use
fecal
serum
sampl
obtain
dr
david
madden
nind
n
h
outbreak
hepat
lynchburg
virginia
train
school
hospit
dr
h
e
bond
look
immun
electron
microscopi
natur
occur
epidem
hepat
feel
found
particl
similar
describ
dr
kapikian
requir
studi
draw
firm
conclus
distribut
dr
kapikian
dr
feinston
purcel
recent
collabor
dr
madden
provid
pair
serum
specimen
patient
develop
hepat
lynchburg
outbreak
determin
hepat
outbreak
associ
serolog
hepat
particl
studi
code
pair
sera
patient
develop
hepat
outbreak
found
patient
develop
signific
serolog
respons
hepat
particl
immun
electron
microscopi
dr
lennett
comment
impel
pass
remark
chairman
concern
potenti
applic
techniqu
describ
dr
kapikian
practic
problem
biomedicin
import
exampl
almost
immedi
come
mind
rapid
identif
variolaviru
immunoelectronmicroscop
approach
describ
dr
kapikian
new
techniqu
describ
dr
oconnor
public
health
offici
countri
alway
alert
possibl
introduct
smallpox
viru
rapid
identif
alway
feasibl
present
circumst
matter
import
sinc
word
laboratori
determin
whether
costli
machineri
vaccin
campaign
put
motion
need
accur
well
rapid
diagnosi
obviou
mani
awar
vaccin
smallpox
longer
requir
countri
action
base
longrecogn
fact
number
advers
reaction
vaccin
outnumb
far
incid
actual
diseas
unless
smallpox
diseas
complet
erad
face
increasingli
import
problem
increas
popul
smallpox
suscept
henc
need
rapid
method
recogn
identifi
viru
suspect
case
variola
introduc
countri
immunoelectron
microscopi
offer
diagnost
aid
smallpox
also
viral
diseas
take
occas
emphas
electron
microscop
longer
instrument
basic
sole
laboratori
engag
sophist
esoter
research
one
found
continu
find
pragmat
applic
diagnost
public
health
clinic
virolog
laboratori
dr
kapikian
ye
think
techniqu
immun
electron
microscopi
could
practic
applic
rapid
diagnosi
certain
diseas
among
smallpox
use
could
assist
determin
etiolog
certain
vesicular
lesion
sinc
specif
antisera
agent
present
vesicular
fluid
could
identifi
addit
viral
agent
vesicl
low
titer
visual
convent
electron
microscopi
techniqu
immun
electron
microscopi
might
enabl
visual
identif
